• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Tobacco Products

Minority Communities and Groups Affected by Tobacco-Related Health Disparities

The U.S. Food and Drug Administration (FDA) Center for Tobacco Products (CTP) held its third Stakeholder Discussion Series session with minority communities and groups affected by tobacco-related health disparities from 8:30 a.m. to 5:00 p.m. on Tuesday, February 8, 2011 at the:

California Endowment Conference Center
1111 Broadway (7th Floor)
Oakland, CA 94607

The U.S. Food and Drug Administration (FDA) Center for Tobacco Products (CTP) is charged with implementing the Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act) with the goal of reducing the tremendous toll of disease and death caused by tobacco product use.

In order to better ensure the opportunity for meaningful engagement and dialogue between CTP and representatives from minority communities and groups affected by tobacco-related health disparities, a limited number of individuals have been invited to actively participate in the discussion.  This approach is based on feedback we have received from stakeholder input on the design of these sessions.  Approximately 30 members of the public -- or additional representatives of the stakeholder groups participating in the meeting -- may observe the session at the meeting site. 

Please see the registration policy for instructions on registering as in person observer or for additional details about the conference line.

Stakeholder Discussion Series Session Materials

Meeting Presentations

If you need assistance to access these documents, please email the FDA Center For Tobacco Products.